Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1086 | 978 | 1118 | 1128 | 1484 | 2752 |
Fund Return | 8.57% | -2.24% | 11.79% | 4.09% | 8.22% | 10.65% |
Place in category | 175 | 661 | 207 | 175 | 161 | 78 |
% in Category | 18 | 72 | 18 | 31 | 31 | 26 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund A DIST GBP | 41.78M | 18.12 | 12.07 | 20.98 | ||
Global Technology Fund W Acc GBP | 1.55B | 11.28 | 11.65 | 22.20 | ||
Global Multi Asset Income Fund I Ag | 17.31M | 1.15 | -0.49 | 5.34 | ||
EM Fund W Acc GBP | 23.83M | 7.84 | -6.16 | 5.86 | ||
European Dynamic Growth Fund W Acc | 18.79M | 2.73 | 1.14 | 10.49 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.92B | 11.21 | 7.04 | 12.01 | ||
Wellington Global Health Care EquiG | 2.09B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.55B | 14.50 | 4.03 | 12.68 | ||
Pharmaceuticals Index Trust F Acc | 254.3K | 7.53 | 5.00 | 9.55 | ||
Pharmaceuticals Index Trust F Dist | 864.24Array | 7.52 | 4.97 | 9.52 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 9.27 | 501.89 | +3.37% | |
Eli Lilly | US5324571083 | 6.87 | 775.61 | -0.39% | |
Novo Nordisk B | DK0062498333 | 6.66 | 771.6 | +0.22% | |
Boston Scientific | US1011371077 | 6.47 | 89.46 | -1.08% | |
AstraZeneca | GB0009895292 | 5.23 | 10,352.0 | -1.47% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Neutral |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review